Camilla Jandus

19PUBLICATIONS
130CO-AUTHORS
Evolutionary computationTumour immunologyMolecular targetsModelling and simulationCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Feb 21, 2026
Mast-cell derived nerve growth factor drives ILC2 pro-tumoral functions in bladder cancer.

Maryline Falquet, Hajar El Ahanidi, Alejandra Gomez-Cadena

|Oct 20, 2025
Targeting SALL4 with an HLA Class I-Restricted TCR for Cancer Immunotherapy.

Myriam Ben Khelil, Maxime Fredon, Nawfel Adib

|Jul 28, 2025
Neural anticipation of virtual infection triggers an immune response.

Sara Trabanelli, Michel Akselrod, Julia Fellrath

|Jun 27, 2025
Engineered CD4 TCR T cells with conserved high-affinity TCRs targeting NY-ESO-1 for advanced cellular therapies in cancer.

Margaux Saillard, Mara Cenerenti, Patrick Reichenbach

|Mar 25, 2025
Selective activation of interleukin-2/interleukin-15 receptor signaling in tumor microenvironment using paired bispecific antibodies.

Julien Montorfani, Eric Hatterer, Laurence Chatel

Pageof 4